Eric Patzer insider trades: Aridis Pharmaceuticals (ARDS) stock purchases
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Eric reports to the SEC
Open-market buys and sales
2 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Jun 24, 2024 | ARDS | ↑ Buy | 714,286 | $0.07 | $50K | Direct | Jun 28, 2024 (4d) |
| Jul 27, 2021 | ARDS | ↑ Buy | 5,175 | $4.84 | $25K | Direct | Jul 27, 2021 (0d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
About Eric Patzer's insider trades
Eric Patzer is a director at Aridis Pharmaceuticals (ARDS). Since Jul 27, 2021, Eric has reported 2 open-market purchases worth $75K and no sales on SEC Form 4. There have been no open-market trades in the last 12 months.
Their filings also include grants and awards (3 filings), option exercises (1 filing), gifts (1 filing). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every ARDS insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.